Literature DB >> 33624385

Discovery and validation of novel biomarkers for detection of cervical cancer.

Zigang Li1, Jianhua Chen2, Shaobo Zhao3, Yajun Li3, Jie Zhou4, Jianghong Liang5, Huifang Tang3.   

Abstract

AIMS: To investigate novel biomarker for diagnosis of cervical cancer, we analyzed the datasets in Gene Expression Omnibus (GEO) and confirmed the candidate biomarker in patient sample.
MATERIALS AND METHODS: We collected major datasets of cervical cancer in GEO, and analyzed the differential expression of normal and cancer samples online with GEO2R and tested the differences, then focus on the GSE63514 to screen the target genes in different histological grades by using the R-Bioconductor package and R-heatmap. Then human specimens from the cervix in different histological grades were used to confirm the top 8 genes expression by immunohistochemical staining using Ki67 as a standard control.
RESULTS: We identified genes differentially expressed in normal and cervical cancer, 274 upregulated genes and 206 downregulated genes. After intersection with GSE63514, we found the obvious tendency in different histological grades. Then we screened the top 24 genes, and confirmed the top 8 genes in human cervix tissues. Immunohistochemical (IHC) results confirmed that keratin 17 (KRT17) was not expressed in normal cervical tissues and was over-expressed in cervical cancer. Cysteine-rich secretory protein-2 (CRISP2) was less expressed in high-grade squamous intraepithelial lesions (HSILs) than in other histological grades.
CONCLUSION: For the good repeatability and consistency of KRT17 and CRISP2, they may be good candidate biomarkers. Combined analysis of KRT17, CRISP2 expression at both genetic and protein levels can determine different histological grades of cervical squamous cell carcinoma. Such combined analysis is capable of improving diagnostic accuracy of cervical cancer.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CRISP2; GEO; KRT17; biomarker; cervical cancer

Mesh:

Substances:

Year:  2021        PMID: 33624385      PMCID: PMC7957177          DOI: 10.1002/cam4.3799

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  46 in total

1.  Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition.

Authors:  H S Zhang; A A Postigo; D C Dean
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Diagnostic performance of HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR assays on formalin-fixed paraffin-embedded cervical tissue specimens from women with cervical cancer.

Authors:  Hye-Young Wang; Geehyuk Kim; Hyemi Cho; Sunghyun Kim; Dongsup Lee; Sunyoung Park; Kwang Hwa Park; Hyeyoung Lee
Journal:  Exp Mol Pathol       Date:  2015-03-31       Impact factor: 3.362

3.  The expression of β-microseminoprotein but not CRISP3 is reduced in ovarian cancer and correlates to survival.

Authors:  Rudi Henriksen; Åke Lundwall; Lene Udby; Per Fernlund
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

4.  [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution].

Authors:  T M Stoenescu; Luminiţa Dana Ivan; Nicoleta Stoenescu; Doina Azoicăi
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  2011 Apr-Jun

5.  Keratin 17 expression in the hard epithelial context of the hair and nail, and its relevance for the pachyonychia congenita phenotype.

Authors:  K M McGowan; P A Coulombe
Journal:  J Invest Dermatol       Date:  2000-06       Impact factor: 8.551

6.  Matrix metalloproteinase-9 is a prognostic marker for patients with cervical cancer.

Authors:  Yi Li; Tao Wu; Beilei Zhang; Yuanqing Yao; Guowu Yin
Journal:  Med Oncol       Date:  2012-06-30       Impact factor: 3.064

7.  Bioconductor: open software development for computational biology and bioinformatics.

Authors:  Robert C Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Marcel Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael Irizarry; Friedrich Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Journal:  Genome Biol       Date:  2004-09-15       Impact factor: 13.583

Review 8.  Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.

Authors:  Katsuhide Ikeda; Genshu Tate; Takao Suzuki; Toshiyuki Mitsuya
Journal:  Gynecol Oncol       Date:  2008-01-14       Impact factor: 5.482

9.  CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III).

Authors:  S Regauer; O Reich
Journal:  Histopathology       Date:  2007-04       Impact factor: 5.087

10.  Introduction of p16INK4a as a surrogate biomarker for HPV in women with invasive cervical cancer in Sudan.

Authors:  Hina Sarwath; Devendra Bansal; Nazik Elmalaika Husain; Mahmoud Mohamed; Ali A Sultan; Shahinaz Bedri
Journal:  Infect Agent Cancer       Date:  2017-09-30       Impact factor: 2.965

View more
  3 in total

Review 1.  Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.

Authors:  Sharon Changshan Wu; Karl Münger
Journal:  Cancers (Basel)       Date:  2021-11-14       Impact factor: 6.639

2.  Increased expression of SYCP2 predicts poor prognosis in patients suffering from breast carcinoma.

Authors:  Hongyan Zheng; Xiaorong Guo; Nan Li; Luyao Qin; Xiaoqing Li; Ge Lou
Journal:  Front Genet       Date:  2022-09-07       Impact factor: 4.772

3.  Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis.

Authors:  Tingting Chen; Juan Zhang; Yinying Wang; Hebing Zhou
Journal:  Dis Markers       Date:  2022-09-29       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.